Published in:
01-03-2006 | Short Report
Phase II, parallel-design study of preoperative combined modality therapy and the matrix metalloprotease (mmp) inhibitor prinomastat in patients with esophageal adenocarcinoma
Authors:
Elisabeth I. Heath, Barbara A. Burtness, Lawrence Kleinberg, Ronald R. Salem, Stephen C. Yang, Richard F. Heitmiller, Marcia I. Canto, Jonathan P. S. Knisely, Mark Topazian, Elizabeth Montgomery, Nancy Tsottles, Yazdi Pithavala, Bridget Rohmiller, Mary Collier, Arlene A. Forastiere
Published in:
Investigational New Drugs
|
Issue 2/2006
Login to get access